Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Diabetologia. 2015 Jan 7;58(3):633–642. doi: 10.1007/s00125-014-3470-y

Fig. 5.

Fig. 5

TNFα induces apoptosis and reduces proliferation in mMSCs and hBMSCs. C3H10T1/2 cells (mMSC) and hBMSCs were treated with TNFα (10 ng/ml) for 24–72 h. Apoptosis was detected using annexin V and cleaved caspase-3 antibody, and proliferation was measured by the BrdU assay. (a, d) Annexin V+ cells per total cell number in mMSCs and hBMSCs, respectively. (b, e) Cleaved caspase-3+ cells per total cell number after 72 h of TNFα treatment in mMSCs and hBMSCs, respectively. (c, f) BrdU levels after serum-stimulated proliferation, measured at absorbance = 450 nm. *p<0.05 vs 0 h treatment